Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

151.73 +1.72 (+1.15%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 857,009
Open 150.87
Bid (Size) 59.00 (1)
Ask (Size) 175.11 (1)
Prev. Close 150.01
Today's Range 148.70 - 152.91
52wk Range 91.86 - 254.15
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Circle's Blockbuster Success Aside, Tether CEO Doesn't Want To Go Public: 'Not Trying To Please' Couple Of JPMorgan Analysts
Paolo Ardoino, CEO of stablecoin issuer Tether (CRYPTO: USDT), said Thursday that the company has no plans to go public, despite Circle Internet Financial’s (NYSE:CRL) success on Wall Street. 
Via Benzinga
Senate Passes GENIUS Act—Coinbase's Brian Armstrong Calls It 'Big Milestone,' Scott Bessent Says Passage Could Drive Stablecoins Into A $3.7 Trillion Market
In a significant development, the Senate passed the GENIUS Act on Tuesday, a bill establishing the country’s first regulatory framework for dollar-pegged stablecoins. 
Via Benzinga

Performance

YTD
-16.9%
-16.9%
1 Month
+12.4%
+12.4%
3 Month
+0.8%
+0.8%
6 Month
-17.3%
-17.3%
1 Year
-25.3%
-25.3%

More News

Read More
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
3 Unpopular Stocks in Hot Water
Via StockStory
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
From Charles River Laboratories International, Inc.
Via Business Wire
Shopify Teams Up With Coinbase, Stripe To Roll Out USDC Stablecoin Payments For Merchants
Via Benzinga
CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
Via StockStory
Topics Animal Testing
Circle Stock Has Popped 271% Since NYSE Debut, Now A KPMG Consultant Says This Is The Next Big Thing After Stablecoins
Via Benzinga
Circle IPO Success Suggests Markets Open To New Listings, Especially From Crypto Businesses, Says SPAC King Chamath Palihapitiya
Via Benzinga
Topics Initial Public Offering
Crypto At 'Point Of No Return,' Says Fireblocks CEO And Here's Why He Is Confident About It
Via Benzinga
Ex-Goldman Executive On Circle's 168% IPO Spike: Don't Rush To Buy Stock As Bankers Engineer A 'Pop' — Cites Facebook Example
Via Benzinga
Topics Initial Public Offering
1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index
Via Chartmill
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
Via StockStory
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
From Charles River Laboratories International, Inc.
Via Business Wire
This Waste Management Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
Via StockStory
Topics Bonds Stocks
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)
Via StockStory
Charles River Laboratories to Present at Bank of America Health Care Conference
From Charles River Laboratories International, Inc.
Via Business Wire
What 10 Analyst Ratings Have To Say About Charles River
Via Benzinga
Charles River Labs Stock Soars On Strategic Review Plan With Elliott: Retail Investors Optimistic
Via Stocktwits
Top S&P500 movers in Wednesday's session
Via Chartmill

Frequently Asked Questions

Is Charles River Laboratories International, Inc. Common Stock publicly traded?
Yes, Charles River Laboratories International, Inc. Common Stock is publicly traded.
What exchange does Charles River Laboratories International, Inc. Common Stock trade on?
Charles River Laboratories International, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Charles River Laboratories International, Inc. Common Stock?
The ticker symbol for Charles River Laboratories International, Inc. Common Stock is CRL on the New York Stock Exchange
What is the current price of Charles River Laboratories International, Inc. Common Stock?
The current price of Charles River Laboratories International, Inc. Common Stock is 151.73
When was Charles River Laboratories International, Inc. Common Stock last traded?
The last trade of Charles River Laboratories International, Inc. Common Stock was at 06/30/25 07:00 PM ET
What is the market capitalization of Charles River Laboratories International, Inc. Common Stock?
The market capitalization of Charles River Laboratories International, Inc. Common Stock is 7.65B
How many shares of Charles River Laboratories International, Inc. Common Stock are outstanding?
Charles River Laboratories International, Inc. Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.